Clinical Trial Update: Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure [Phase 2]

View source ↗

Summary

Phase 2 trial updating cabozantinib in advanced or metastatic cervical cancer after platinum failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Advanced/Metastatic Cervical Cancer | Phase 2 | Status: COMPLETED